By repurposing an existing drug, researchers say that they can prevent seizures in an extremely rare form of epilepsy and possibly create future lines of attack against more common types of the disorder. The researchers previously had determined that the disease’s genetic mutation blocked the function of a protein that regulates cell growth and movement. "It is like a thermostat," said senior author Peter Crino, a professor of neurology at Temple.